About MediciNova, Inc.
https://www.medicinova.comMediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States.
CEO
Yuichi Iwaki
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 3
Ratings Snapshot
Rating : B-
Most Recent Analyst Grades
Grade Summary
Showing Top 2 of 2
Price Target
Institutional Ownership
BLACKROCK FUND ADVISORS
Shares:1.42M
Value:$2.05M
ESSEX WOODLANDS MANAGEMENT, INC.
Shares:1.11M
Value:$1.59M
VANGUARD GROUP INC
Shares:700.38K
Value:$1.01M
Summary
Showing Top 3 of 37
About MediciNova, Inc.
https://www.medicinova.comMediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $123.32K ▼ | $3.34M ▼ | $-3.05M ▲ | -2.47K% ▼ | $-0.06 ▲ | $-3M ▲ |
| Q2-2025 | $134.6K ▲ | $3.63M ▲ | $-3.28M ▼ | -2.44K% ▼ | $-0.07 ▼ | $-3.6M ▼ |
| Q1-2025 | $0 | $3.2M ▲ | $-2.86M ▼ | 0% | $-0.06 ▼ | $-3.2M ▼ |
| Q4-2024 | $0 | $3.18M ▼ | $-2.81M ▲ | 0% | $-0.06 ▲ | $-3.18M ▲ |
| Q3-2024 | $0 | $3.31M | $-2.85M | 0% | $-0.06 | $-3.3M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $32.56M ▼ | $47.58M ▼ | $3.61M ▲ | $43.96M ▼ |
| Q2-2025 | $34.26M ▼ | $49.82M ▼ | $2.97M ▲ | $46.86M ▼ |
| Q1-2025 | $36.57M ▼ | $52.43M ▼ | $2.5M ▼ | $49.93M ▼ |
| Q4-2024 | $40.36M ▼ | $55.88M ▼ | $3.37M ▲ | $52.5M ▼ |
| Q3-2024 | $42.28M | $58.12M | $3.05M | $55.07M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-3.05M ▲ | $-1.7M ▲ | $-2.9K ▼ | $0 | $-1.7M ▲ | $-1.71M ▲ |
| Q2-2025 | $-3.28M ▼ | $-2.31M ▲ | $0 | $0 | $-2.31M ▲ | $-2.31M ▲ |
| Q1-2025 | $-2.86M ▼ | $-3.78M ▼ | $0 ▼ | $0 | $-3.79M ▼ | $-3.78M ▼ |
| Q4-2024 | $-2.81M ▲ | $-1.93M ▲ | $1 ▼ | $0 | $-1.92M ▲ | $-1.93M ▲ |
| Q3-2024 | $-2.85M | $-2.03M | $193 | $0 | $-2.06M | $-2.03M |
CEO
Yuichi Iwaki
Compensation Summary
(Year 2024)
ETFs Holding This Stock
Summary
Showing Top 3 of 3
Ratings Snapshot
Rating : B-
Most Recent Analyst Grades
Grade Summary
Showing Top 2 of 2
Price Target
Institutional Ownership
BLACKROCK FUND ADVISORS
Shares:1.42M
Value:$2.05M
ESSEX WOODLANDS MANAGEMENT, INC.
Shares:1.11M
Value:$1.59M
VANGUARD GROUP INC
Shares:700.38K
Value:$1.01M
Summary
Showing Top 3 of 37